Overall, analyses of gathered data upon effectiveness of EPO supplementation in inflammatory diseases revealed that EPO publicized the most positive results in AE, mastalgia and RA, reducing disease symptoms and promoting improvements. The gene discussed is EPO; the disease is rheumatoid arthritis.